Suzanne Vernon Ph.D. on the RECOVER Initiative and ME/CFS, Peroxisomes, the Gut, Viral Persistence and Upcoming Treatment Trials
Suzanne Vernon’s interest in pathogens and post-infectious diseases goes back to when, as a 20-year-old, she landed a work-study job at the CDC’s Division of Vector-Borne Diseases while an undergraduate at Colorado State University. Ten years later with...
Lighting a Spark: Major New Long-COVID Initiative Promises Rapid Movement
It’s nice to have a billionaire in your corner. Earlier this year, billionaire Vitalik Buterin pledged to devote $100 million to high-risk, high-reward COVID-19 efforts. He made good on at least $15 million of that when he jumpstarted The Long COVID...
Ischemia-Reperfusion Hypothesis Opens New Treatment Options for Long COVID, Fibromyalgia and ME/CFS
Ischemia–reperfusion injury, hypoxia–reperfusion injury, or reoxygenation injury – whatever name you wish to call it – occurs when a low oxygen state in the tissues is followed by a resumption of normal oxygen flows. Oddly enough, it’s during the...
The Long-COVID Treatment Trials Thus Far: Winners, Losers and the In-Betweeners
“Consider that larger clinical trials are often meant to confirm something important to change our practice. The small trials are the ones making conceptual breakthroughs that change our thinking.” Aaron Cypess, M.D., Ph.D., M.M.Sc., National Institute of...
“How Long?” For People with Long COVID, asks Powerful National Public Service Announcement
How long, indeed? Some people with long COVID are now entering their third miserable year with the illness. They can’t be happy. Their doctors are at a loss. Treatment trials are underway, but most are too small or poorly run to light up the medical world. The...Lives Interrupted Latest Story
Bob Graybosch
Lahaina, United States
Former occupation: Resort General Manager
$1,261,443
StudyME
Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.
